These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8106066)

  • 61. Bilateral cavitary pulmonary consolidations in a patient undergoing allogeneic bone marrow transplantation for acute leukemia.
    Hiltermann TJ; Bredius RG; Gesink-vd Veer BJ; Corrin B; Rabe KF; Brahim JJ
    Chest; 2003 Mar; 123(3):929-34. PubMed ID: 12628896
    [No Abstract]   [Full Text] [Related]  

  • 62. Bone marrow transplantation in first remission.
    Rowe JM
    Leukemia; 1997 May; 11 Suppl 4():S12-4. PubMed ID: 9179274
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Resolution of celiac disease, IgA deficiency and platelet refractoriness after allogeneic bone marrow transplantation for acute leukemia.
    Zandi S; Kanfar S; Cserti-Gazdewich C; Lipton JH; Pendergrast J
    Haematologica; 2019 Mar; 104(3):e121-e123. PubMed ID: 30655374
    [No Abstract]   [Full Text] [Related]  

  • 64. Allogeneic bone marrow transplantation.
    Franco T; Gould DA
    Semin Oncol Nurs; 1994 Feb; 10(1):3-11. PubMed ID: 8165377
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Successful nonmyeloablative allogeneic hematopoietic stem cell transplant in an acute leukemia patient with chemotherapy-induced marrow aplasia and progressive pulmonary aspergillosis.
    Xun CQ; McSweeney PA; Boeckh M; Storb RF; Broudy VC; Thompson JA
    Blood; 1999 Nov; 94(9):3273-6. PubMed ID: 10610124
    [No Abstract]   [Full Text] [Related]  

  • 66. Gene transfer and bone marrow transplantation.
    Brenner MK; Heslop HE; Rill D; Li C; Nilson T; Roberts M; Smith C; Krance R; Rooney C
    Cold Spring Harb Symp Quant Biol; 1994; 59():691-7. PubMed ID: 7587132
    [No Abstract]   [Full Text] [Related]  

  • 67. Supportive care of the marrow transplant recipient: the Seattle Experience.
    Sullivan KM; Meyers J; Petersen FB; Bowden R; Counts GC; Banaji M; Schubert M; Clark J; Clift RA; Appelbaum FR
    Haematol Blood Transfus; 1990; 33():539-45. PubMed ID: 2182446
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Fatal primary cutaneous aspergillosis in a bone marrow transplant recipient: nosocomial acquisition in a laminar-air flow room.
    Bretagne S; Bart-Delabesse E; Wechsler J; Kuentz M; Dhédin N; Cordonnier C
    J Hosp Infect; 1997 Jul; 36(3):235-9. PubMed ID: 9253705
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Peripheral blood CD5-positive B lymphocytes (B-1a cells) after allogeneic stem cell transplantation for acute myeloid leukaemia in humans.
    Veneri D; Franchini M; de Sabata D; Ledro S; Vella A; Ortolani R; Pizzolo G; Benedetti F
    Blood Transfus; 2008 Oct; 6(4):220-4. PubMed ID: 19112737
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Current concepts in autologous bone marrow transplantation.
    Crouch MA; Ross JA
    Semin Oncol Nurs; 1994 Feb; 10(1):12-9. PubMed ID: 8165374
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Guidelines on the use of colony-stimulating factors in haematological malignancies.
    Pagliuca A; Carrington PA; Pettengell R; Tule S; Keidan J;
    Br J Haematol; 2003 Oct; 123(1):22-33. PubMed ID: 14510939
    [No Abstract]   [Full Text] [Related]  

  • 72. Marrow vs peripheral blood: impact on transplant outcome.
    Forman SJ
    Leukemia; 2001 Apr; 15(4):686-7. PubMed ID: 11368382
    [No Abstract]   [Full Text] [Related]  

  • 73. Fatal cerebral toxoplasmosis in a bone marrow transplant recipient with leukemia.
    Löwenberg B; van Gijn J; Prins E; Polderman AM
    Transplantation; 1983 Jan; 35(1):30-4. PubMed ID: 6337434
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Immune modulation in bone marrow transplant.
    Kulkarni S; Parikh PM
    Indian J Med Sci; 1996 May; 50(5):177-82. PubMed ID: 8979537
    [No Abstract]   [Full Text] [Related]  

  • 75. Supportive care in marrow transplantation.
    Bensinger WI
    Curr Opin Oncol; 1992 Aug; 4(4):614-23. PubMed ID: 1511018
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Biology and clinical application of peripheral blood stem cells.
    Shea TC; Mason JR
    Curr Top Microbiol Immunol; 1992; 177():205-14. PubMed ID: 1353430
    [No Abstract]   [Full Text] [Related]  

  • 77. Fatal disseminated aspergillosis following sequential heart and stem cell transplantation for systemic amyloidosis.
    Razonable RR; Patel R; Wilhelm MP; Gertz MA; Litzow MR; Inwards DJ; Dearani JA; Edwards BS; McGregor CG
    Am J Transplant; 2001 May; 1(1):93-5. PubMed ID: 12095046
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The transfusion needs of an autologous bone marrow transplant patient with IgA deficiency.
    Meena-Leist CE; Fleming DR; Heye M; Herzig RH
    Transfusion; 1999 May; 39(5):457-9. PubMed ID: 10335993
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Overview of the role of hematopoietic growth factors in bone marrow transplant recovery and bone marrow transplant failure.
    Nemunaitis J
    Support Care Cancer; 1994 Nov; 2(6):374-6. PubMed ID: 7858929
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Allogeneic peripheral blood progenitor cell transplantation in solid tumors.
    Ueno NT; Hortobagyi GN; Champlin RE
    Cancer Treat Res; 1999; 101():133-56. PubMed ID: 10800648
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.